Avantor Revenue 2018-2024 | AVTR

Avantor revenue for the twelve months ending June 30, 2024 was $6.826B, a 4.88% decline year-over-year.

  • Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
  • Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
  • Avantor annual revenue for 2021 was $7.386B, a 15.52% increase from 2020.

Avantor Revenue 2018-2024 | AVTR

  • Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
  • Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
  • Avantor annual revenue for 2021 was $7.386B, a 15.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$126B
Cencora (COR)$46.2B
ICON (ICLR)$24.1B
DiDi Global (DIDIY)$18.8B
Natera (NTRA)$15.7B
Revvity (RVTY)$15.1B
Viatris (VTRS)$14.1B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.5B
Medpace Holdings (MEDP)$11B
Charles River Laboratories (CRL)$10.6B
Sonic Healthcare (SKHHY)$8.9B
Doximity (DOCS)$7.5B
HealthEquity (HQY)$6.9B
Bausch + Lomb (BLCO)$6.5B
PACS (PACS)$6.2B
Organon (OGN)$5.3B
Life Times (LTH)$4.9B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4B
Concentras Parent (CON)$2.9B
GoodRx Holdings (GDRX)$2.9B
BrightSpring Health Services (BTSG)$2.5B
Ardent Health Partners (ARDT)$2.5B
Progyny (PGNY)$2.2B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2.1B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.8B
CareDx (CDNA)$1.6B